NHLBI
-
November 15, 2018
Vanderbilt study suggests way to prevent rare lung disease
Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs. -
November 8, 2018
Obesity negates beneficial drug effects
A drug that improves levels of “good” cholesterol may not be beneficial for obese individuals, Vanderbilt researchers have discovered. -
November 7, 2018
Low health literacy associated with early death for cardiovascular patients
Patients hospitalized with a cardiovascular event are more likely to die within one year if they have low health literacy, according to a Vanderbilt University Medical Center study released this week in Mayo Clinic Proceedings. -
November 1, 2018
Team’s findings show glutamine metabolism affects T cell signaling
The cellular nutrient glutamine launches a metabolic signaling pathway that promotes the function of some immune system T cells and suppresses others, Vanderbilt researchers have discovered. -
October 12, 2018
Asthma’s androgen connection
New findings may explain why the prevalence of asthma is higher in women and suggest that testosterone derivatives may be useful for treating more severe types of asthma. -
October 11, 2018
Watkins lecturer focuses on research, inspirations
André Churchwell, MD, welcomed those gathered at the 17th Annual Levi Watkins Jr., MD Lecture on Tuesday with a reminder of who they were honoring and why. -
September 27, 2018
Stretch, inflammation and hypertension
New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.